Net Margin - Accelerate Diagnostics Inc (NASDAQ:AXDX) - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.476 USD 0.41%
Market Cap: 34.9m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Net Margin
Accelerate Diagnostics Inc

-309.9%
Current
-546%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-309.9%
=
Net Income
-37.9m
/
Revenue
12.2m

Net Margin Across Competitors

Country US
Market Cap 34.8m USD
Net Margin
-310%
Country US
Market Cap 198.5B USD
Net Margin
14%
Country US
Market Cap 173.7B USD
Net Margin
28%
Country US
Market Cap 138.8B USD
Net Margin
16%
Country US
Market Cap 124B USD
Net Margin
12%
Country IE
Market Cap 114.6B USD
Net Margin
12%
Country US
Market Cap 67.7B USD
Net Margin
7%
Country DE
Market Cap 55.7B EUR
Net Margin
8%
Country US
Market Cap 42.9B USD
Net Margin
22%
Country US
Market Cap 40.8B USD
Net Margin
25%
Country US
Market Cap 41.3B USD
Net Margin
8%

Profitability Report

View the profitability report to see the full profitability analysis for Accelerate Diagnostics Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-309.9%
=
Net Income
-37.9m
/
Revenue
12.2m
What is the Net Margin of Accelerate Diagnostics Inc?

Based on Accelerate Diagnostics Inc's most recent financial statements, the company has Net Margin of -309.9%.